First, patients who received 6 or more vaccine doses showed a trend toward improved survival (MST 18 months) compared to those receiving fewer doses (MST 17 months), although this difference did not reach statistical significance ( P = .39).
← all excerpts
Postoperative dendritic cell vaccination in brain metastasis: A real-world retrospective cohort study evaluating survival and safety.
1
—
—